Research Development - AVROBIO Inc (NASDAQ:TECX) - Alpha Spread

AVROBIO Inc
NASDAQ:TECX

Watchlist Manager
AVROBIO Inc Logo
AVROBIO Inc
NASDAQ:TECX
Watchlist
Price: 19 USD 1.88% Market Closed
Market Cap: 279.9m USD
Have any thoughts about
AVROBIO Inc?
Write Note

AVROBIO Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AVROBIO Inc
Research & Development Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
AVROBIO Inc
NASDAQ:TECX
Research & Development
-$47.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Research & Development
-$7.5B
CAGR 3-Years
-2%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Research & Development
-$5.7B
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Research & Development
-$5.4B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Research & Development
-$3.4B
CAGR 3-Years
-7%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Research & Development
-$4.7B
CAGR 3-Years
-18%
CAGR 5-Years
-13%
CAGR 10-Years
-16%

See Also

What is AVROBIO Inc's Research & Development?
Research & Development
-47.7m USD

Based on the financial report for Dec 31, 2023, AVROBIO Inc's Research & Development amounts to -47.7m USD.

What is AVROBIO Inc's Research & Development growth rate?
Research & Development CAGR 1Y
34%

Over the last year, the Research & Development growth was 34%.

Back to Top